Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019)
Enanta Pharmaceuticals (ENTA) posted Capital Leases of $200000.0 for Q3 2019, down 10.71% on a QoQ basis from $224000.0 in Q2 2019, and down 31.74% year-over-year from $293000.0 in Q3 2018.
Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019) Analysis & Trends
Enanta Pharmaceuticals' Capital Leases history runs 5 years deep, the most recent figure standing at $200000.0 for Q3 2019.
- Quarterly Capital Leases fell 31.74% year-over-year to $200000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $200000.0 (down 31.74% YoY) and the FY2019 annual result came in at $200000.0, down 31.74% from the prior year.
- Capital Leases was $200000.0 for Q3 2019 at Enanta Pharmaceuticals, down from $224000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $529000.0 in Q3 2015 and bottomed at $175000.0 in Q2 2015.
- A 5-year average of $364166.7 and a median of $368500.0 in 2017 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2016 — Capital Leases soared 173.14% — and 2019, when it sank 31.74%.
- Enanta Pharmaceuticals' Capital Leases stood at $513000.0 in 2015, then retreated by 14.23% to $440000.0 in 2016, then fell by 18.64% to $358000.0 in 2017, then fell by 24.3% to $271000.0 in 2018, then declined by 26.2% to $200000.0 in 2019.
- Business Quant data shows ENTA's Capital Leases at $200000.0 in Q3 2019, $224000.0 in Q2 2019, and $249000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 224,000.00 |
| Mar 31, 2019 | 249,000.00 |
| Dec 31, 2018 | 271,000.00 |
| Sep 30, 2018 | 293,000.00 |
| Jun 30, 2018 | 315,000.00 |
| Mar 31, 2018 | 337,000.00 |
| Dec 31, 2017 | 358,000.00 |
| Sep 30, 2017 | 379,000.00 |
| Jun 30, 2017 | 402,000.00 |
| Mar 31, 2017 | 421,000.00 |
| Dec 31, 2016 | 440,000.00 |
| Sep 30, 2016 | 458,000.00 |
| Jun 30, 2016 | 478,000.00 |
| Mar 31, 2016 | 513,000.00 |
| Dec 31, 2015 | 513,000.00 |
| Sep 30, 2015 | 529,000.00 |
| Jun 30, 2015 | 175,000.00 |